Amit Rupani

3PUBLICATIONS
34CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Tumour immunologyCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (3)

|May 01, 2025
Avelumab induces greater Fc-Fc receptor-dependent natural killer cell activation and dendritic cell crosstalk compared to durvalumab.

Nicole Osborne, Amit Rupani, Vladimir Makarov

|May 17, 2024
LRIG1 engages ligand VISTA and impairs tumor-specific CD8+ T cell responses.

Hieu Minh Ta, Dia Roy, Keman Zhang

|Oct 26, 2023
Phase II Clinical Trial of Pembrolizumab and Chemotherapy Reveals Distinct Transcriptomic Profiles by Radiologic Response in Metastatic Triple-Negative Breast Cancer.

Avia D Wilkerson, Prerana Bangalore Parthasarathy, Nickolas Stabellini

Pageof 1

Frequent Collaborators

3 joint publications

Timothy Chan

2 joint publications

Prerana Bangalore Parthasarathy

2 joint publications

Tyler Alban

1 joint publications

Avia D Wilkerson